Updates in Clinical Care: Family Medicine and Pharmacogenomics Medication Optimization and Collaborative Care

Updates in Clinical Care: Family Medicine and Pharmacogenomics Medication Optimization and Collaborative Care is organized by Continuing Education, Inc. and will be held from Jun 18 - 25, 2023 at Celebrity Eclipse, Vancouver, British Columbia, Canada.

Program Purpose:
• Current Management of Type 2 Diabetes
       • "Identify patients at risk of developing Type 2 Diabetes and strategies for delaying the progression of the disease
       • Describe the latest pharmacologic management options & their indications
       • Define several of the common quality indicators for Diabetes and strategies for improvement

• Neurocognitive Disorders of the older adult
       • Identify risk factors for & possible ways to slow cognitive decrease
       • Define approaches to assess cognitive efficiency
       • Identify currently offered therapy choices for patients with MCI as well as Mental deterioration

• Updates in Hyperlipidemia Management
       • Make use of the latest management advice for preventing primary and secondary ASCVD

• Prevention and Management of Osteoporosis: The Impact on the Individual
       • Identify the risk factors associated with osteoporosis and apply evidence-based screening methods to determine the risk of osteoporosis.
       • Describe the importance of aggressive treatment of Osteoporosis.

• Current Evidence in Obesity Management
       • Describe how the latest guidelines can be applied to the practical evaluation and treatment of obese patients, including weight loss pharmacotherapy, by the latest guidelines.

• Atrial Fibrillation Management: Impacting Quality of Life and Stroke Risk
       • Identify appropriate anticoagulation strategies for atrial fibrillation following the interpretation of practice guidelines.

• Dermatologic diseases of aging skin for non-dermatologic practitioners
       •Establish and carry out therapy concepts for common conditions affecting the skin and nails of older patients that are not malignant.

• Hypertension Guidelines and Controversies
       • Acknowledge the principles of and the evidence for pharmacological and non-pharmacological management of the hypertensive patient, and have a good understanding of both.

• From Pharmacogenomics to Personalized Medicine
       • Recognize brand-new individual medical care innovations and also the effect they might carry on client results.
       • Distinguish the advantages and limitations of genetic testing and its use in managing drugs in certain people.
      • Review numerous gene-drug (biomarker-drug) coupled with pharmacogenomic applications.
      • Review the various sources (e.g., CPIC, PharmGKB, FDA) for pharmacogenomics drug-gene pairs.
      • Understand the difference between preemptive and reactive testing of drug-gene pairs.
      • Discuss the financial expense or effect factors connected to pharmacogenomic testing.
      • Understand practical techniques for counseling/patient education related to pharmacogenomics.

• Optimizing Medication Adherence and Outcomes
    • Develop and implement methods to increase adherence to prescribed medications among all healthcare providers
    • Describe low adherence's impact on patients' clinical and economic results; this is important for all parties involved.
    • Identify the necessary places within the system of using medications at which technology can be implemented to reduce the risk of medical errors and improve the outcomes for patients

• Comprehensive Medication Management Services
   • Outline the value of leveraging the prescription benefit to reduce downstream healthcare costs and outcomes
   • Critique the rationale for collaborative models of care that deliver enhanced clinical, patient, and economic outcomes that involve pharmaceutical benefits
   • Recognize the importance of aligning incentives in a pay-for-performance? a Model that includes all providers